A report on the US Food and Drug Administration's (FDA) enforcement
record by US Democratic lawmakers has highlighted a plunge in the
number of warning letters the agency has sent to drug manufacturers
since 2000, citing several...
The new US Food and Drug Administration (FDA) Commissioner - Andrew
von Eschenbach - has stepped down as director of the National
Cancer Institute after his ability to carry out both roles in
tandem was questioned.
In the US, Altor BioScience has received a phase I Small Business
Innovation Research (SBIR) grant from the National Cancer Institute
(NCI) to support development of its processes for making
therapeutic antibodies in transgenic lettuce.
As reported last week, Mark McClellan looks set to leave his post
as Commissioner of the US Food and Drug Administration (FDA) to run
the agency that oversees Medicare and its new prescription drug
programme for the elderly and disabled.
The cost of implementing the US Medicare Act - which for the first
time provides a prescription drug benefit for the elderly and
disabled - is rising fast and represents a 'cave-in' to the drug
industry by the US government.
The US government's attempt to reform the federal Medicare system
to provide a prescription benefit for the elderly and disabled has
been slammed by the Democrats, who believe it will prevent US
states from negotiating price...
New legislation in the US to give the elderly and disabled rights
to reimbursement for prescription drugs under the federal Medicare
system has been passed by the Senate. It has been estimated that
the measure could expand the revenues...